Matches in SemOpenAlex for { <https://semopenalex.org/work/W3156814910> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W3156814910 abstract "<h3>Background</h3> Small-for-gestational-age (SGA) infants are at-risk of hyperinsulinemic hypoglycemia (HH), requiring high glucose infusion rates (GIR) to maintain euglycemia. <h3>Objectives</h3> To compare the outcomes of SGA infants treated with diazoxide (DZX) versus watchful waiting (WW) with high GIR and feeds in the management of HH. <h3>Methods</h3> This observational study was conducted from September 2014 to September 2020. SGA infants with HH (GIR >10 mg/kg/min, plasma glucose level < 3.0 mmol/l with detectable insulin) were identified. Data on sex, gestational age (GA), birth weight (BW), age at presentation, symptoms, critical investigations, GIR, dose and duration of DZX treatment, and outcomes were analyzed. <h3>Results</h3> 56 SGA infants were identified – 27 DZX and 29 WW, male infants being 56% and 62% respectively. Mean GA were 36.4(31–40) for DZX and 36(30–39) weeks for WW. BW were 1942±356 vs 1873±498 gm respectively. 96.4% of infants presented on day 1 of life. More DZX treated infants had symptomatic HH (DZX, 22% vs WW, 7%; p=0.227). Paired glucose/insulin levels were 2.37±0.47 mmol/L/16.39±27.4 mU/L in DZX and 2.45±0.65 mmol/L/8.65±11.3 mU/L in WW cohort (p=0.196). Maximum GIR in DZX cohort was 14.8±4.3 vs 13.1±3.2 mg/kg/min in WW (p=0.097). Mean day of DZX initiation was 12.9±8.2 days with an average treatment duration of 65 days and the maximum dose was 4.6±2.2 mg/kg/day. Duration of central venous line, day of resolution, and day to discharge were not statistically different between the two cohorts. However, infants who had DZX initiation <10d vs >10d of life had earlier resolution of HH (p=0.013). <h3>Conclusions</h3> Spontaneous resolution does occur in SGA infants with high GIR and feeds. DZX being a K<sub>ATP</sub>channel agonist, its use should be restricted to symptomatic infants requiring persistently high GIR, especially in early days of life, as the DZX related long-term outcome is unclear. Duration of intensive care treatment for HH was not statistically different between the two cohorts." @default.
- W3156814910 created "2021-04-26" @default.
- W3156814910 creator A5004942506 @default.
- W3156814910 creator A5009806653 @default.
- W3156814910 creator A5030856342 @default.
- W3156814910 creator A5067033163 @default.
- W3156814910 creator A5071984586 @default.
- W3156814910 creator A5079039693 @default.
- W3156814910 date "2021-04-01" @default.
- W3156814910 modified "2023-09-24" @default.
- W3156814910 title "151 Role of diazoxide therapy in small for gestational age infants with prolonged hyperinsulinemic hypoglycemia" @default.
- W3156814910 doi "https://doi.org/10.1136/bmjpo-2021-rcpch.85" @default.
- W3156814910 hasPublicationYear "2021" @default.
- W3156814910 type Work @default.
- W3156814910 sameAs 3156814910 @default.
- W3156814910 citedByCount "0" @default.
- W3156814910 crossrefType "proceedings-article" @default.
- W3156814910 hasAuthorship W3156814910A5004942506 @default.
- W3156814910 hasAuthorship W3156814910A5009806653 @default.
- W3156814910 hasAuthorship W3156814910A5030856342 @default.
- W3156814910 hasAuthorship W3156814910A5067033163 @default.
- W3156814910 hasAuthorship W3156814910A5071984586 @default.
- W3156814910 hasAuthorship W3156814910A5079039693 @default.
- W3156814910 hasBestOaLocation W31568149101 @default.
- W3156814910 hasConcept C126322002 @default.
- W3156814910 hasConcept C134018914 @default.
- W3156814910 hasConcept C187212893 @default.
- W3156814910 hasConcept C2778376644 @default.
- W3156814910 hasConcept C2779234561 @default.
- W3156814910 hasConcept C2779306644 @default.
- W3156814910 hasConcept C2779872217 @default.
- W3156814910 hasConcept C2780668416 @default.
- W3156814910 hasConcept C2780938740 @default.
- W3156814910 hasConcept C54355233 @default.
- W3156814910 hasConcept C71924100 @default.
- W3156814910 hasConcept C72563966 @default.
- W3156814910 hasConcept C86803240 @default.
- W3156814910 hasConceptScore W3156814910C126322002 @default.
- W3156814910 hasConceptScore W3156814910C134018914 @default.
- W3156814910 hasConceptScore W3156814910C187212893 @default.
- W3156814910 hasConceptScore W3156814910C2778376644 @default.
- W3156814910 hasConceptScore W3156814910C2779234561 @default.
- W3156814910 hasConceptScore W3156814910C2779306644 @default.
- W3156814910 hasConceptScore W3156814910C2779872217 @default.
- W3156814910 hasConceptScore W3156814910C2780668416 @default.
- W3156814910 hasConceptScore W3156814910C2780938740 @default.
- W3156814910 hasConceptScore W3156814910C54355233 @default.
- W3156814910 hasConceptScore W3156814910C71924100 @default.
- W3156814910 hasConceptScore W3156814910C72563966 @default.
- W3156814910 hasConceptScore W3156814910C86803240 @default.
- W3156814910 hasLocation W31568149101 @default.
- W3156814910 hasOpenAccess W3156814910 @default.
- W3156814910 hasPrimaryLocation W31568149101 @default.
- W3156814910 hasRelatedWork W2051290654 @default.
- W3156814910 hasRelatedWork W2057434408 @default.
- W3156814910 hasRelatedWork W2068108356 @default.
- W3156814910 hasRelatedWork W2068655959 @default.
- W3156814910 hasRelatedWork W2098040797 @default.
- W3156814910 hasRelatedWork W2102284920 @default.
- W3156814910 hasRelatedWork W2113905390 @default.
- W3156814910 hasRelatedWork W2117329905 @default.
- W3156814910 hasRelatedWork W2121663374 @default.
- W3156814910 hasRelatedWork W2152166036 @default.
- W3156814910 isParatext "false" @default.
- W3156814910 isRetracted "false" @default.
- W3156814910 magId "3156814910" @default.
- W3156814910 workType "article" @default.